Hodges Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Hodges Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,809	Closed	-$279K	–	210
2023 Q3	$279K	Buy	+4,809	New	+$295K	0.03%	189
2023 Q2	–	Sell	-12,506	Closed	-$839K	–	183
2023 Q1	$811K	Sell	12,506 -835	-6%	-$58.9K	0.07%	164
2022 Q4	$960K	Sell	13,341 -4,711	-26%	-$355K	0.08%	150
2022 Q3	$1.28M	Sell	18,052 -1,073	-6%	-$77.8K	0.21%	107
2022 Q2	$1.47M	Sell	19,125 -852	-4%	-$64.9K	0.15%	115
2022 Q1	$1.46M	Sell	19,977 -1,541	-7%	-$103K	0.12%	130
2021 Q4	$1.34M	Sell	21,518 -6,141	-22%	-$360K	0.1%	134
2021 Q3	$1.64M	Sell	27,659 -17,036	-38%	-$1.12M	0.12%	129
2021 Q2	$2.99M	Buy	44,695 +16,692	+60%	+$1.09M	0.33%	99
2021 Q1	$1.77M	Buy	28,003 +9,552	+52%	+$594K	0.24%	108
2020 Q4	$1.15M	Sell	18,451 -303	-2%	-$18.6K	0.18%	126
2020 Q3	$1.13M	Buy	18,754 +1,051	+6%	+$63.3K	0.22%	112
2020 Q2	$1.04M	Buy	17,703 +5,602	+46%	+$335K	0.21%	111
2020 Q1	$675K	Sell	12,101 -49	-0.4%	-$3K	0.17%	108
2019 Q4	$780K	Buy	+12,150	New	+$696K	0.1%	132
2016 Q3	–	Sell	-2,800	Closed	-$206K	–	274
2016 Q2	$206K	Buy	+2,800	New	+$198K	0.01%	259

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hodges Capital Management's BMY Position: Q4 2023 in Review

Hodges Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 4,809 shares — an estimated $279K sold.

Hodges Capital Management first reported a position in BMY in Q2 2016 and held it in 16 quarters. The position peaked at $2.99M in Q2 2021. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Hodges Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Hodges Capital Management sold 4,809 Bristol-Myers Squibb shares in Q4 2023, an estimated $279K.
Hodges Capital Management first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 16 quarters.
Hodges Capital Management's Bristol-Myers Squibb position peaked at $2.99M in Q2 2021.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Hodges Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.